Skip to main content

Table 1 Clinical characteristics of the enrolled patients

From: Effects of a luteinizing hormone-releasing hormone agonist on cognitive, sexual, and hormonal functions in patients with prostate cancer: relationship with testicular and adrenal androgen levels

n

45

 

Age (±SD)

67.5 ± 3.5

 

PSA (±SD)

13 ± 10.7

 

G.S.

6

1

7

28

8

9

9

7

T

T1c

12

T2a

1

T2b

7

T2c

7

T3a

17

T3b

1

Risk group

Intermediate

16

High

29

  1. PSA: prostate specific antigen.
  2. G.S. Gleason score.
  3. T:T category of TNM Classification of Malignant Tumours 7th Edition.
  4. Risk group: D’Amico risk stratification.
Back to article page

Basic and Clinical Andrology

ISSN: 2051-4190